The US Food and Drug Administration (FDA) has completed an audit of the BioScreen Testing Services, Inc. laboratory facility located in Torrance, CA. BioScreen hosted the FDA on June 16 and June 18, 2014. The successful completion of this audit for which no 483 citations were issued, indicates BioScreen's continued commitment in offering its clients cGMP and GLP laboratory testing services. The inspection of our quality system as well as all laboratory facilities included the expanded chemistry and microbiology laboratories.
"The results from the FDA audit are extremely positive and serve as a testament to the high quality standards that BioScreen sets for itself," said Ranil M. Fernando, executive vice president, BioScreen.
BioScreen's President, Bradford Rope added, "We are extremely pleased to share this news with our valued customers to indicate the robustness of our quality system."
BioScreen Testing Services is a contract testing laboratory servicing the needs of medical device, pharmaceutical and personal care industries. BioScreen specializes in performing analytical chemistry, human clinical trials, microbiological and toxicological studies for FDA regulated companies.
More info: BioScreen Testing Services, Torrance, CA USA; Tel: 310-214-0043; Website: www.bioscreen.com